Search Tag: Masimo
Masimo Announces FDA Clearance of Radius PCG™ for Root® Patient Monitoring & Connectivity Platform
2021 12 Apr
Masimo (NASDAQ: MASI) announced today that Radius PCG™, a portable real-time capnograph with wireless Bluetooth® connectivity, has received FDA 510(k) clearance. Radius PCG connects with the Root® Patient Monitoring and Connectivity Platform to provide seamless, tetherless mainstream capnography for patients of all ages. Radius PCG joins the growing... Read more
Masimo to Present in 20th Annual Needham Healthcare Conference
2021 07 Apr
Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the 20th Annual Needham Healthcare Conference on Monday, April 12, 2021 at 3:45 p.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. Read more
Study Investigates the Effects of Rescue Therapies on the Cerebral Oxygenation of COVID-19 Patients
2021 06 Apr
Study Stresses the Importance of Brain Monitoring During the Treatment of Patients with Severe COVID-19 Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Critical Care in which researchers in Genoa, Italy, evaluated the impact of a variety of rescue therapies on the systemic and cerebral oxygenation... Read more
Study Investigates Impact of Automating Respiration Rate Measurement Using Masimo Rad-G™ with RRp®
2021 29 Mar
Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Acta Paediatrica in which researchers from the Hospital for Sick Children in Toronto evaluated the accuracy of plethysmographic respiration rate measurement (RRp®) using Masimo Rad-G™, a rugged, handheld device, on malnourished, hospitalized children... Read more
Sri Lankan Study Expands Evidence of the Benefits of CCHD Screening Using Masimo SET® Pulse Oximetry
2021 22 Mar
Masimo today announced the results of a prospective study published in the Sri Lanka Journal of Child Health in which researchers in Colombo, Sri Lanka evaluated the efficacy of a pulse oximetry-based critical congenital heart disease (CCHD) newborn screening strategy using Masimo SET® pulse oximetry. 1 The authors concluded that pulse oximetry... Read more
FDA Clearance for Masimo O3® Regional Oximetry for Extended Use in Cerebral & Somatic Applications
2020 31 Aug
Masimo today announced that O3® Regional Oximetry has received FDA clearance for expanded use in monitoring somatic tissue oxygenation saturation in all patient populations and monitoring relative changes in hemoglobin, oxyhemoglobin, and deoxyhemoglobin in adult brains. With this FDA clearance, O3 is now indicated for use in both cerebral and somatic... Read more
New Studies Investigate the Accuracy of Masimo SpHb® on Neonates
2020 19 Aug
Masimo today announced that in a study recently published in the Journal of Tropical Pediatrics, researchers evaluating Masimo SpHb® (noninvasive, continuous hemoglobin monitoring) on neonatal patients concluded that the technology “offers reliable Hb [hemoglobin] values, which are comparable with the more traditional tHb [invasive venous blood... Read more
New Blinded Observational Study Shows Greater Depth of Sedation Than Intended During Colonoscopy
2020 03 Aug
Masimo SedLine® Brain Function Monitoring with PSi Processed EEG Helped Identify the Oversedations Masimo today announced that in a new study published in Anesthesia Research and Practice, researchers used Masimo SedLine® Brain Function Monitoring to investigate the depth of anesthesia of patients receiving propofol for outpatient colonoscopy,... Read more
Masimo Expands the Masimo SafetyNet™️ Solution with Continuous Body Temperature Measurement
2020 27 Jul
The Radius Tº™ Wearable Temperature Sensor Automates Remote Monitoring of Patient Temperature Status Masimo today announced a significant expansion to the Masimo SafetyNet™ platform with the introduction of Radius Tº™, a wearable, wireless sensor that provides continuous body temperature measurements. By augmenting the already powerful Masimo... Read more
New Study Expands Evidence of the Benefits of CCHD Screening Using Masimo SET® Pulse Oximetry
2020 20 Jul
Masimo today announced the results of a prospective study published in the International Journal of Neonatal Screening in which researchers in Marrakesh, Morocco, conducted the first Moroccan study on critical congenital heart disease (CCHD) screening for newborns using Masimo SET® pulse oximetry.1 The authors concluded that “Our results encourage... Read more